TECH Key Statistics
High
72.12
Open
71.60
Volume
3.07M
Low
71.50
Prev. Close
71.77
Trading Value
221.03M
52-Week High
72.16
Relative Volume
0.367
Amplitude (%)
0.86%
52-Week Low
43.20
Turnover Rate
1.96%
Market Cap
11.18B
P/E Ratio (TTM)
103.59
P/E Ratio (Annual)
153.447
P/B Ratio
5.39
P/S Ratio
9.28
Earnings Per Share (EPS)
0.696
Dividend (TTM)
0.317
Dividend Yield
0.45%
Shares Outstanding
156.56M
Currency Unit
USD
TECH Price Performance
7 day
30 day
90 day
180 day
Year to date
1 Year
TECH Money Flow Distribution
TECH Daily Short Sale Volume
TECH Short Interest History
TECH Stock Snapshot
As of 2026-07-18, the Bio-Techne Corp (TECH) stock price today is 72.12. Based on this price, the company has a market capitalization of $11.18B, with a P/E ratio of 103.59.
On 2026-07-18, TECH traded between 71.50 and 72.12. Today’s stock price is 0.87% above the daily low and 0.00% below the daily high, placing TECH near the upper end of its most recent trading range.
Trading volume currently stands at 3.07M, compared with an average daily volume of 8.38M. This suggests that trading activity is significantly below its usual level than usual.
Over the past year, Bio-Techne Corp shares have traded between 43.20 and 72.16. At today’s price, TECH is 66.94% above its 52-week low and 0.06% below its 52-week high.
TECH Related News
About TECH
Company Name
Bio-Techne Corp
Sector
Health Technology
Industry
Biotechnology
Exchanges
Nasdaq
Number of Employees
3,100
Lot Size
100
Official Website
Currency Unit
USD
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Related Stocks
© 2026 CoinGlass, all rights reserved
